NCT02007902

Brief Summary

The primary aim of this study is to investigate the relationship between early plasma protein levels and hemodynamics in very preterm infants during postnatal transition. Secondary aims are the following: i) to evaluate maternal and neonatal factors affecting plasma protein level at birth; ii) to evaluate the relationship between plasma protein level and albumin level on the first day of life; iii) to evaluate the association between early hypoproteinemia and neonatal mortality and morbidity in very preterm infants.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
125

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Jan 2014

Geographic Reach
1 country

2 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

November 25, 2013

Completed
16 days until next milestone

First Posted

Study publicly available on registry

December 11, 2013

Completed
21 days until next milestone

Study Start

First participant enrolled

January 1, 2014

Completed
1.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 1, 2015

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

March 1, 2015

Completed
Last Updated

October 1, 2018

Status Verified

September 1, 2018

Enrollment Period

1.2 years

First QC Date

November 25, 2013

Last Update Submit

September 28, 2018

Conditions

Keywords

Preterm babyTotal plasma proteinAlbuminHemodynamic disturbancesPerfusionNear Infra Red Spectroscopy (NIRS)Ultrasound

Outcome Measures

Primary Outcomes (1)

  • Evidence of clinical hemodynamic disturbances defined by arterial hypotension (non-invasive measure of MAP - mmHg - pathological for gestational age) or measured at organ colour doppler, echocardiography or NIRS

    about 6 hours after birth

Secondary Outcomes (3)

  • plasma protein

    at 1 second after birth (cord blood sample)

  • Albumin level

    At 12 hours after birth

  • Mortality rate

    patients will be followed for the duration of hospital stay, that is an average of 8 weeks

Study Arms (1)

Very preterm babies

Observational model: cohort

Other: Evaluation of the relationship plasma protein levels - neonatal hemodynamics

Interventions

* Patient inclusion at birth * Total plasma protein values measurement on cord blood sample at birth * Hemodynamic evaluation at 6 hours after birth with colour doppler echocardiography and organ blood flow colour doppler * Total plasma protein and albumin values measurement on plasma sample at 12 hours after birth * Blood pressure, heart rate, O2 saturation, capillary refill time, rSO2 \[regional (cerebral and somatic) tissue oxygenation by NIRS - near infrared spectroscopy\] will be monitored over 24 hours after birth.

Very preterm babies

Eligibility Criteria

Age1 Minute - 1 Hour
Sexall
Healthy VolunteersYes
Age GroupsChild (0-17)
Sampling MethodNon-Probability Sample
Study Population

Very preterm infants with birth at less than 32 weeks of gestational age

You may qualify if:

  • Parents written informed consent
  • Birth at less than 32 weeks of gestational age
  • Birth in a III level delivery facility at Reunion Island

You may not qualify if:

  • Major congenital abnormalities

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

Centre Hopsitalier Universitaire de La Réunion

Saint-Denis, La Réunion, 97405, France

Location

Centre Hospitalier de La Réunion

Saint-Pierre, La Réunion, 97448, France

Location

Study Officials

  • Silvia Iacobelli

    CHU de La Réunion -Site du GHSR

    PRINCIPAL INVESTIGATOR
  • Sylvain Samperiz, MD

    CHU de La Réunion - Hôpital Félix Guyon

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

November 25, 2013

First Posted

December 11, 2013

Study Start

January 1, 2014

Primary Completion

March 1, 2015

Study Completion

March 1, 2015

Last Updated

October 1, 2018

Record last verified: 2018-09

Locations